BGB Group Executive and Leadership Team

David Coman, the Chief Executive Officer at BGB Group, directs the overarching strategic vision and operational execution for the marketing communications firm. Coman guides the company's focus on supporting the promotional and educational objectives of biotech, medical device, and pharmaceutical clients. Overseeing all major client engagements, the Chief Executive Officer ensures alignment with BGB Group's mission to deliver impactful marketing solutions. This leadership role involves fostering innovation within the agency and driving growth across key therapeutic areas. By championing client-centric strategies, David Coman directly influences the company's market position and reputation within the life sciences sector. Ultimately, Coman secures long-term client partnerships and sustainable business development.

Kenneth Lambe, the Chief Financial Officer at BGB Group, manages all financial operations and fiscal strategy for the marketing communications company. Lambe oversees budgeting, forecasting, and financial reporting, ensuring the fiscal health and stability of the organization. Directing the finance department, the Chief Financial Officer supports the company's objectives in serving biotech, medical device, and pharmaceutical clients. This critical role involves optimizing financial performance and resource allocation to maximize client service delivery and operational efficiency. By implementing robust financial controls, Kenneth Lambe directly contributes to BGB Group's ability to invest in talent and technology. Ultimately, Lambe safeguards the company's assets and drives profitability through sound financial management.

Teresa Day, the President at BGB Group, drives operational excellence and strategic client partnerships for the marketing communications firm. Day oversees the execution of marketing and educational programs tailored for biotech, medical device, and pharmaceutical clients. Leading the operational teams, the President ensures seamless project delivery and client satisfaction across all engagements. This executive function involves fostering cross-departmental collaboration and optimizing workflows to enhance service quality. By focusing on client success and market responsiveness, Teresa Day directly impacts BGB Group's reputation and growth within the life sciences industry. Ultimately, Day strengthens the company's ability to achieve its clients' promotional and educational objectives.

Kit Kempler, the Chief People Officer at BGB Group, leads all human capital strategies and organizational development initiatives. Kempler oversees talent acquisition, employee engagement, and professional development programs designed to support the company's specialized client base. Directing the human resources function, the Chief People Officer ensures a high-performing and motivated workforce capable of meeting the unique demands of biotech, medical device, and pharmaceutical marketing. This position involves cultivating a positive and inclusive company culture that attracts and retains top talent. By championing employee well-being and career growth, Kit Kempler directly enhances BGB Group's capacity to deliver exceptional client service. Ultimately, Kempler builds a strong organizational foundation essential for sustained business success.

Eric Brandel, the Executive Vice President & Supervisor, Managing at BGB Group, spearheads key client initiatives and manages critical project portfolios. Brandel directs the execution of complex marketing and educational campaigns for the company's biotech, medical device, and pharmaceutical clientele. Overseeing the managing director function, the Executive Vice President & Supervisor, Managing ensures that client objectives are met with precision and strategic insight. This role involves leading teams to develop and implement innovative communication strategies that resonate within the life sciences sector. By driving successful campaign outcomes, Eric Brandel directly contributes to client retention and the expansion of BGB Group's service offerings. Ultimately, Brandel solidifies the company's position as a trusted partner in client success.

Alexander Thompson, the Executive Vice President & Associate Managing Director at BGB Group, supports the strategic direction and operational management of client accounts. Thompson oversees the development and implementation of promotional and educational strategies for clients in the biotech, medical device, and pharmaceutical industries. Leading the associate managing director function, the Executive Vice President & Associate Managing Director ensures effective project oversight and team coordination. This position involves fostering strong client relationships and identifying opportunities for enhanced engagement and service delivery. By driving project success and client satisfaction, Alexander Thompson directly contributes to BGB Group's market standing and revenue growth. Ultimately, Thompson reinforces the company's commitment to achieving client objectives through expert marketing communications.